Diseases of the pleura, pleural cavity and chest walls
For developmental
defects, see pediatric surgery.
Pneumothorax
There is air entering
pleural space in pneumothorax (PNO). It leads to pressure equalization between
pleural cavity and external environment and to lung collapse. Etiology may be
either traumatic or spontaneous or iatrogenic. The trauma can be penetrating
(stab wound, gunshot wound) or blunt (rib fractures, parenchymal tear). In
spontaneous PNO, air enters pleural space from a ruptured bulla or emphysema.
Primary spontaneous PNO arises from healthy parenchyma, typically in young,
tall men. Secondary spontaneous PNO occurs in already diseased lung (COPD,
sarcoidosis, pneumonia). Iatrogenic PNO is produced during central venous
canulation or pleural fluid puncture.
Pathophysiological
division of PNO is as follows: In closed PNO, there is no air communication
between pleural and external spaces, the air entering either from the lung or
from a penetrating wound, which seals well. In open PNO, there is air
flow through the injury and subsequent mediastinal flailing and corrupted
ventilation mechanics occurs, if the square area of the communication is large
enough. Tension or valve PNO is produced by on-way air entry into the
pleural space. Progressive rise of intrapleural pressure occurs. Ipsilateral
lung collapse is followed by contralateral mediastinal shift, superior and
inferior vena cava compression, decreased venous return and acute circulatory
failure. Morphological description includes complete PNO (complete lung
collapse) and partial PNO (with part of the lung fixed with adhesions to
the chest wall).
PNO clinically
presents as dyspnea, hypoxia, chest pain, diminished or absent breathing
sounds, hyperresonant percussion. In tension PNO, hemodynamic compromise with
hypotension, tachycardia, paleness and loss of consciousness may be present.
Plain chest x-ray is performed. If unclear, CT scan provides detailed
information. PNO is managed with chest tube insertion. Very small pneumothorax
(less than 3cm) may be observed only with serial imaging.
Hemothorax
It is characterized
by the presence of blood in the pleural cavity. Etiology is traumatic (rib
fractures, injuries to the lung parenchyma, heart, large vessels, chest wall vessels)
or iatrogenic (postoperative bleeding, after CSF puncture, chest drainage or
lung biopsy). Depending on the volume, it can be small (<500 ml), medium sized
(500-1500 ml) or large (>1500 ml). Standard history is taken. On clinical
exam, dyspnea, signs of hemorrhagic shock, hypotension, tachyarrhythmias,
pallor and even impaired consciousness are present. On the chest, there are auscultatory
findings of diminished breathing, percussion dullness, decreased to absent
phremitus pectoralis. Two projection chest x-ray and ultrasound are used as
first line imaging methods to determine the amount of pleural fluid. Contrast
enhanced CT scan is more accurate in determining the quantity and distribution
of blood and possibly showing the etiology. Pleural punction can further verify
hemothorax, if unclear on imaging studies. For small hemothorax, observation
alone is warranted. For larger hemothorax, relieving pleural punction or large
bore chest tube insertion with suction is used. Blood products are administered
according to laboratory values and transfusion principles. Surgical treatment
is indicated according to the patient's condition and the chest tube output (watch
out for clot blockage!!!). Several rules can be followed: 1. One-time discharge
of 1000-1500ml of blood and hemodynamical compromise present; 2. Output greater
than 300 ml/h in the following 3 hours; 3. Output greater than 200 ml/h in the
following 5 hours. Stable patients may benefit from initial miniinvasive
approach (VATS), but thoracotomy in the unstable is urgently performed. During
the operation, the source of the bleeding is found and adequately treated, all
blood and blood clots are cleared to prevent adhesions formation and empyema.
Chest empyema
It is characterized
by the presence of pus or infected effusion in the pleural cavity. It most
often arises in pneumonias, as parapneumonic empyema. It may also arise in lung
abscess, bronchial obstruction (e.g. bronchogenic carcinoma), after TB, in pneumothorax
with persistent bronchopleural fistula, after penetrating trauma to the chest, as
secondarily infected hemothorax, after esophageal perforation, in the presence
of subphrenic abscess, osteomyelitis, pleuritis, cholecystitis, after thoracic
surgery, or hematogenously. The bacteria involved are usually Streptococcus
pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Haemophilus
influensae, Bacteroides, Peptostreptococcus.
It develops in three
stages: I. acute, exudative stage, days 2-5, sometimes only 48 hours,
the effusion is clear or slightly turbid, the lung is free, capable to re-expand,
culture tends to be negative. Biochemically, leukocyte level in the exudate is low,
LDH, pH and glucose are normal. Transitional II. fibropurulent stage,
day 5-10, effusion thickens, fibrin is deposited on the pleura, forming a
membrane that encapsulates the effusion and thus fixes the lung and prevents
re-expansion. Effusion polymorphonuclear count increases, pH <7.2, glucose
<60 mg/dl, LDH increases, culture may be positive or negative. III.
chronic, organized stage, forms after 2-4 weeks, empyema sac forms rigid membrane,
thick purulent effusion, trapped lung, unable to re-expand.
Diagnostic process
starts with taking a history. On clinical examination, fever, tachypnea,
tachycardia, weakened phremitus pectoralis and weakened breathing sounds are
found. The signs of sepsis may be present. Laboratory markers of inflammation
are increased, and X-ray, ultrasound and CT with contrast are performed.
Thoracocentesis with collection of effusion for culture and biochemistry may
follow. Treatment consists of remediation of the infection with antibiotics and
drainage. Conventional chest drainage is indicated as the first step. If the
empyema is at an early stage, it can be cured. With a longer-standing empyema,
septa are already forming and fibrothorax is present. Therefore, drainage
becomes difficult and complete evacuation is impossible and subsequent re-expansion
of the lung does not occur. Large bore chest tubes are used (26-32 Ch). CT
guided drainage of the collection can be performed using a pig-tail drain (8-14
Ch). Fibrinolytics (streptokinase, urokinase, rTPA) are sometimes used.
Surgical therapy consists of VATS salvage, or thoracotomy with eventual
decortication of the lung at the second time. If the entire empyema sac can be
removed, the procedure is referred to as empyemectomy. In some cases,
thoracoplasty is performed or pleurostoma is established (see figures in the
presentation).
Chest drainage
The aim of thoracic drain
(also chest tube, intercostal drain, thoracostomy tube, etc.) is to 1) evacuate
pathological contents of pleural cavity and 2) restore normal pressure
conditions and 3) achieve re-expansion of the lung.
Chest drainage may be
active or passive. Water seal system like Bülau drainage is an example of passive
drainage. Intrapleural pressure rises during expiration and air or fluid is
expelled to the drainage system (e.g. one bottle) through water (water level 2
cm). During inspiration, negative pressure sucks water several centimeters up
the tube, but air is prevented from entering. Caution! The drainage system must
be placed below the level of the patient. Otherwise, fluid could be sucked into
the pleural cavity. However, as the level of fluid collected in the bottle
increases, resistance raises and drainage may become ineffective. Therefore, chest
drainage must be managed by qualified personnel.
Heimlich valve is another
passive drainage device. It acts as a one-way valve. It allows air and fluid to
escape from the pleural cavity, but on inspiration the valve collapses and does
not allow air nor fluid to re-enter. The valve is connected to the drain on one
side and to the collecting bag on the other side.
Active drainage is used
whenever passive drainage system does not achieve lung re-expansion. The system
contains 2 or 3 bottles. The first bottle is the collecting bottle, the second
bottle is a 2 cm water lock, and the third bottle regulates the maximum
negative pressure by the water column (usually 15 cm). The suction force is
determined by the difference between the two water levels. From the third
bottle, one tube exits to the atmosphere, another is connected to the vacuum
source (central suction, suction pump). The vacuum is set between 10 and 20
cmH2O (most often 12 or 15). With a three-bottle system, there is a greater
risk of air entering the pleural cavity if the system is disconnected before
the second bottle. In a two-bottle system, the first collection bottle is
missing and the secretion from the second bottle must be drained regularly.
There are commercially
manufactured sets where the three-bottle system is built into a plastic box. Electronic
drainage system is the most modern alternative. It consists of a collection
vessel, a manometer and a suction source. The display shows the vacuum value
(-8 cmH2O represents “passive” water seal), air leak in ml/min, the amount of
secretion evacuated and graphical trends over selected periods of time. Another
advantage is the small size which does not hinder patients from verticalization
and early rehabilitation. An alarm is also included to alert of any errors.
Absolute indications for
thoracic drainage include tension pneumothorax, bilateral pneumothorax,
pneumothorax in ventilated patient (the patient must be disconnected from the ventilator
during drain insertion), recurrent and persistent pneumothorax, empyema,
hemothorax, traumatic and postoperative chylothorax, and symptomatic effusions.
Relative indications for
thoracic drainage may include non-traumatic and idiopathic chylothorax,
recurrent malignant effusion, and bulky effusion of cardiac etiology if
pleurodesis is planned.
There are only relative contraindications
depending on the drainage indication, most commonly coagulopathy, chest wall
inflammation.
Chest tube insertion
We recommend the blunt
dissection technique, which is safer than the trocar technique. The site for
drain insertion is chosen either in the second intercostal space in the
medioclavicular line (Monaldi) or better in the fifth intercostal space in a
safe triangle at the level of the mammilla behind the pectoralis muscle
(Bülau). Targeted drain insertion in other locations is possible under CT or
ultrasound guidance.
The procedure for drain
insertion is as follows. The patient is informed and consent is signed. Prepare
the equipment and position the patient. Aseptic technique is applied, disinfect
and debride the surgical field, apply local anesthesia. Skin incision of about
2 cm (for the finger) is made, blunt dissection proceeds through thoracic wall
at the upper edge of the rib. Parietal pleura is also penetrated bluntly with a
finger and the nearby pleural cavity is palpated to exclude adhesions. Drain is
introduced through the dissected channel and directed to the apex for PNO or to
the costo-phrenic angle for effusion. Bent or straight tube of 24-32Ch thickness
is used. CAVE! Never insert the tube against resistance, there is a risk of
injury to intrathoracic structures! Fluid comes out of the pleural cavity or
mist can be seen in the tube, if placed intrapleurally. Finally, the drain
needs to be secured with sutures and connected to the drainage system. Chest
x-ray is performed 2 hours after the procedure, or even sooner, depending on
the patient's condition. We check the tube position and intrathoracic organs.
Give analgesics a monitor the patient (oxygen saturation, BP, PR). Drain output
of fluid and air is also monitored. Air draining out of the chest is referred
to as air-leak. It comes from lung parenchymal tear, broncho-pleural fistula or
from improper seal of soft tissue and skin around the tube. Effusions of
various nature, blood or lymph may be drained. The fluid is sent for
microbiological culture, biochemical examination (to distinguish between exudate
and transudate), cytological examination. Depending on differential diagnosis, Mycobacteria
may need to be proved (culture, PCR), cytological). We perform a check-up chest
x-ray every time the drain is manipulated (e.g. change of suction pressure, tube
removal…). Depending on the amount, nature and duration of secretion/air leak,
the drain is removed or surgical revision is indicated. In recurrent non-infectious
effusions (most often malignant) and with complete lung re-expansion after
evacuation, pleurodesis (e.g. talc) can be performed.
Chest wall tumors
They are divided into
primary, secondary and direct tumor invasion from the surrounding tissues and
organs. There are benign tumors: lipoma, fibroma, chondroma, osteochondroma,
neurilemoma. Semimalignant: desmoid. Malignant: malignant mesothelioma of the
pleura, osteosarcoma, rhabdomyosarcoma, chondrosarcoma, leiomyosarcoma,
liposarcoma, Ewing's sarcoma, neurofibrosarcoma, hemangiosarcoma, lymphoma,
plasmocytic myeloma, malignant histiocytoma. Solitary fibrous tumor of the
pleura is mostly benign but with malignant potential. Diagnostic methods
include clinical examination, CT, MRI, PET/CT. Treatment of these cases is
multidisciplinary and should be performed in specialized centers. Therapy is
mainly surgical, as these tumors are very often chemo-radio resistant.